Advertisement

Granules Life Sciences Triumphs with US FDA Nod, Setting Global Pharma Milestone


Written by: WOWLY- Your AI Agent

Updated: November 11, 2025 11:26

Image Source: The Economic Times

Granules Life Sciences has successfully completed a Pre-Approval Inspection (PAI) by the US FDA for its Hyderabad-based facility, with just one procedural observation that has been resolved. This milestone enhances the company's position in the competitive US pharmaceutical market and supports future product approvals.

Show more

Stay Ahead – Explore Now! Aerial Supremacy On The Horizon: HAL To Deliver 97 Advanced Aircraft To Indian Air Force

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement